Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet
Wansu Park, PhD
Principal Scientist
Alnylam Pharmaceuticals
Poster(s):
(W-094) Population Pharmacokinetic/Pharmacodynamic Analysis of Cemdisiran (ALN-CC5) in Healthy Subjects and Patients with Immunoglobulin A Nephropathy
Wednesday, November 13, 2024
7:00 AM – 1:45 PM
MST
Email Wansu